Catheter-Directed Thrombolysis Protocols for Deep Venous Thrombosis of the Lower Extremities—A Systematic Review and Meta-analysis

Abstract

Objective To summarize characteristics, complications, and success rates of different catheter-directed thrombolysis (CDT) protocols for the treatment of lower extremity deep venous thrombosis (LE-DVT).

Methods A systematic review using electronic databases (MEDLINE, Scopus, and Web of Science) was performed to identify randomized controlled trials and observational studies related to LE-DVT treated with CDT. A random-effects model meta-analysis was performed to obtain the pooled proportions of early complications, postthrombotic syndrome (PTS), and venous patency.

Results Forty-six studies met the inclusion criteria reporting 49 protocols (n = 3,028 participants). In studies that addressed the thrombus location (n = 37), LE-DVT had iliofemoral involvement in 90 ± 23% of the cases. Only four series described CDT as the sole intervention for LE-DVT, while 47% received additional thrombectomy (manual, surgical, aspiration, or pharmacomechanical), and 89% used stenting.

Definition of venogram success was highly variable, being the Venous Registry Index the most used method (n = 19). Among those, the minimal thrombolysis rate (<50% lysed thrombus) was 0 to 53%, partial thrombolysis (50–90% lysis) was 10 to 71%, and complete thrombolysis (90–100%) was 0 to 88%. Pooled outcomes were 8.7% (95% confidence interval [CI]: 6.6–10.7) for minor bleeding, 1.2% (95% CI: 0.8–1.7%) for major bleeding, 1.1% (95% CI: 0.6–1.6) for pulmonary embolism, and 0.6% (95% CI: 0.3–0.9) for death. Pooled incidences of PTS and of venous patency at up to 1 year of follow-up were 17.6% (95% CI: 11.8–23.4) and 77.5% (95% CI: 68.1–86.9), respectively.

Conclusion Assessment of the evidence is hampered by the heterogeneity of protocols, which may be reflected in the variation of PTS rates. Despite this, CDT is a low-risk treatment for LE-DVT.

Keywords

deep venous thrombosis - thrombolysis - protocols - systematic review - meta-analysis

Publikationsverlauf

Eingereicht: 18. Dezember 2022

Angenommen: 02. Juni 2023

Accepted Manuscript online:
06. Juni 2023

Artikel online veröffentlicht:
24. Juli 2023

• References

• 1 Raskob GE, Angchaisuksiri P, Blanco AN. et al; ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014; 34 (11) 2363-2371
• 2 Prandoni P, Lensing AW, Prins MH. et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004; 141 (04) 249-256
• 3 Haig Y, Enden T, Grøtta O. et al; CaVenT Study Group. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol 2016; 3 (02) e64-e71
• 4 Kakkos SK, Gohel M, Baekgaard N. et al; Esvs Guidelines Committee. Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis. Eur J Vasc Endovasc Surg 2021; 61 (01) 9-82
• 5 Enden T, Haig Y, Kløw NE. et al; CaVenT Study Group. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012; 379 (9810): 31-38
• 6 Vedantham S, Goldhaber SZ, Julian JA. et al; ATTRACT Trial Investigators. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017; 377 (23) 2240-2252
• 7 Ashrafi M, Ahmad SB, Antoniou SA, Khan T, Antoniou GA. Treatment strategies for proximal deep vein thrombosis: a network meta-analysis of randomised controlled trials. Eur J Vasc Endovasc Surg 2022; 63 (02) 323-334
• 8 Moher D, Shamseer L, Clarke M. et al; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4 (01) 1
• 9 Okrent D, Messersmith R, Buckman J. Transcatheter fibrinolytic therapy and angioplasty for left iliofemoral venous thrombosis. J Vasc Interv Radiol 1991; 2 (02) 195-197 , discussion 198–200
• 10 Munn Z, Barker TH, Moola S. et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth 2020; 18 (10) 2127-2133
• 11 Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH. Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw 2012; 49 (05) 1-15
• 12 Semba CP, Razavi MK, Kee ST, Sze DY, Dake MD. Thrombolysis for lower extremity deep venous thrombosis. Tech Vasc Interv Radiol 2004; 7 (02) 68-78
• 13 Bjarnason H, Kruse JR, Asinger DA. et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol 1997; 8 (03) 405-418
• 14 Verhaeghe R, Stockx L, Lacroix H, Vermylen J, Baert AL. Catheter-directed lysis of iliofemoral vein thrombosis with use of rt-PA. Eur Radiol 1997; 7 (07) 996-1001
• 15 Chen G, Shi W, He X, Lou W, Chen L, Gu J. Feasibility of continuous, catheter-directed thrombolysis using low-dose urokinase in combination with low molecular-weight heparin for acute iliofemoral venous thrombosis in patients at risk of bleeding. Exp Ther Med 2017; 13 (02) 751-758
• 16 Mewissen MW. Catheter-directed thrombolysis for lower extremity deep vein thrombosis. Tech Vasc Interv Radiol 2001; 4 (02) 111-114
• 17 Ogawa T, Hoshino S, Midorikawa H, Sato K. Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with acute proximal venous thrombosis of the leg. J Vasc Surg 2005; 42 (05) 940-944
• 18 Kim HS, Patra A, Paxton BE, Khan J, Streiff MB. Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes. J Vasc Interv Radiol 2006; 17 (07) 1099-1104
• 19 Park YJ, Choi JY, Min SK. et al. Restoration of patency in iliofemoral deep vein thrombosis with catheter-directed thrombolysis does not always prevent post-thrombotic damage. Eur J Vasc Endovasc Surg 2008; 36 (06) 725-730
• 20 Martinez Trabal JL, Comerota AJ, LaPorte FB, Kazanjian S, DiSalle R, Sepanski DM. The quantitative benefit of isolated, segmental, pharmacomechanical thrombolysis (ISPMT) for iliofemoral venous thrombosis. J Vasc Surg 2008; 48 (06) 1532-1537
• 21 Gao B, Zhang J, Wu X. et al. Catheter-directed thrombolysis with a continuous infusion of low-dose urokinase for non-acute deep venous thrombosis of the lower extremity. Korean J Radiol 2011; 12 (01) 97-106
• 22 Manninen H, Juutilainen A, Kaukanen E, Lehto S. Catheter-directed thrombolysis of proximal lower extremity deep vein thrombosis: a prospective trial with venographic and clinical follow-up. Eur J Radiol 2012; 81 (06) 1197-1202
• 23 Lee CY, Lai ST, Shih CC, Wu TC. Short-term results of catheter-directed intrathrombus thrombolysis versus anticoagulation in acute proximal deep vein thrombosis. J Chin Med Assoc 2013; 76 (05) 265-270
• 24 Lee JH, Kwun WH, Suh BY. The results of aspiration thrombecomy in the endovascular treatment for iliofemoral deep vein thrombosis. J Korean Surg Soc 2013; 84 (05) 292-297
• 25 Gomaa M, Fahmy H, Farouk A. Catheter direct thrombolysis: role of actilyse in treatment of acute deep venous thrombosis. Egypt J Radiol Nucl Med 2013; 44: 57-62
• 26 Park KM, Moon IS, Kim JI. et al. Mechanical thrombectomy with Trerotola compared with catheter-directed thrombolysis for treatment of acute iliofemoral deep vein thrombosis. Ann Vasc Surg 2014; 28 (08) 1853-1861
• 27 Xue GH, Huang XZ, Ye M. et al. Catheter-directed thrombolysis and stenting in the treatment of iliac vein compression syndrome with acute iliofemoral deep vein thrombosis: outcome and follow-up. Ann Vasc Surg 2014; 28 (04) 957-963
• 28 Engelberger RP, Spirk D, Willenberg T. et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv 2015; 8 (01) 8
• 29 Duan PF, Ni CF. Randomized study of different approaches for catheter-directed thrombolysis for lower-extremity acute deep venous thrombosis. J Formos Med Assoc 2016; 115 (08) 652-657
• 30 Li FH, Zhao Y, Wang XH, Fu QN, Liu H, Huang W. Risk factors associated with symptomatic pulmonary embolism of catheter directed thrombolysis for lower extremity deep venous thrombosis. Eur J Vasc Endovasc Surg 2015; 50 (05) 658-663
• 31 Fiengo L, Bucci F, Khalil E, Salvati B. Original approach for thrombolytic therapy in patients with Ilio-femoral deep vein thrombosis : 2 years follow-up. Thromb J 2015; 13: 40
• 32 Mizuno A, Anzai H, Utsunomiya M. et al; EDO registry investigators. Real clinical practice of catheter therapy for deep venous thrombosis: periprocedural and 6-month outcomes from the EDO registry. Cardiovasc Interv Ther 2015; 30 (03) 251-259
• 33 Yang B, Xu XD, Gao P. et al. Catheter-directed thrombolysis via small saphenous veins for treating acute deep venous thrombosis. Med Sci Monit 2016; 22: 2972-2980
• 34 Sundar G, Keshava SN, Moses V. et al. Outcomes of catheter-directed treatment of lower extremity deep vein thrombosis of patients presenting to a tertiary care hospital. Indian J Radiol Imaging 2016; 26 (01) 73-80
• 35 Zou J, Jiao Y, Jiang J. et al. Quantitation of venous clot lysis with D-dimer assay during catheter-directed thrombolysis for lower extremity deep venous thrombosis. Int Surg 2016; 101: 487-491
• 36 Tichelaar VY, Brodin EE, Vik A. et al. A retrospective comparison of ultrasound-assisted catheter-directed thrombolysis and catheter-directed thrombolysis alone for treatment of proximal deep vein thrombosis. Cardiovasc Intervent Radiol 2016; 39 (08) 1115-1121
• 37 Foegh P, Jensen LP, Klitfod L, Broholm R, Bækgaard N. Editor's Choice - factors associated with long-term outcome in 191 patients with ilio-femoral DVT treated with catheter-directed thrombolysis. Eur J Vasc Endovasc Surg 2017; 53 (03) 419-424
• 38 Kuo TT, Huang CY, Hsu CP, Lee CY. Catheter-directed thrombolysis and pharmacomechanical thrombectomy improve midterm outcome in acute iliofemoral deep vein thrombosis. J Chin Med Assoc 2017; 80 (02) 72-79
• 39 Lin M, Hsieh JCF, Hanif M, McDaniel A, Chew DK. Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral-popliteal venous segment involvement. J Vasc Surg Venous Lymphat Disord 2017; 5 (05) 613-620
• 40 Zhu C, Zhuo H, Qin Y, Zhang W, Qiu J, Ran F. Comparison of clear effect and the complications, and short and mid-term effects between ultrasound-guided and non-guided catheter-directed thrombolysis in the treatment of deep venous thrombosis of lower extremity. Vascular 2019; 27 (03) 277-283
• 41 Wang H, Qi X, Chen Y, Sun J. A retrospective study comparing 2 approaches to catheter-directed thrombolysis for acute deep venous thrombosis. Ann Vasc Surg 2018; 50: 30-37
• 42 Liu G, Liu X, Wang R. et al. Catheter-directed thrombolysis of acute entire limb deep vein thrombosis from below the knee access: a retrospective analysis of a single-center experience. Catheter Cardiovasc Interv 2018; 91 (02) 310-317
• 43 Yu H, Du X, Li W, Song D, Li X, Gao P. The midterm effect of iliac vein stenting following catheter-directed thrombolysis for the treatment of deep vein thrombosis. Ann Vasc Surg 2018; 50: 1-7
• 44 Jeon YS, Yoon YH, Cho JY. et al. Catheter-directed thrombolysis with conventional aspiration thrombectomy for lower extremity deep vein thrombosis. Yonsei Med J 2010; 51 (02) 197-201
• 45 Baker R, Samuels S, Benenati JF, Powell A, Uthoff H. Ultrasound-accelerated vs standard catheter-directed thrombolysis--a comparative study in patients with iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2012; 23 (11) 1460-1466
• 46 Lu T, Loh TM, El-Sayed HF, Davies MG. Single-center retrospective review of ultrasound-accelerated versus traditional catheter-directed thrombolysis for acute lower extremity deep venous thrombosis. Vascular 2017; 25 (05) 525-532
• 47 Yin SW, Guo LW, Bian L, Xiang TM, Pan SQ. Evaluation of percutaneous mechanical thrombectomy via the AngioJet system combined with catheter-directed thrombolysis for the treatment of symptomatic lower extremity deep venous thrombosis. Ann Vasc Surg 2020; 65: 66-71
• 48 Pouncey AL, Gwozdz AM, Johnson OW. et al. AngioJet pharmacomechanical thrombectomy and catheter directed thrombolysis vs. catheter directed thrombolysis alone for the treatment of iliofemoral deep vein thrombosis: a single centre retrospective cohort study. Eur J Vasc Endovasc Surg 2020; 60 (04) 578-585
• 49 Notten P, Arnoldussen CWKP, Brans R. et al. Association of successful ultrasound-accelerated catheter-directed thrombolysis with postthrombotic syndrome: a post hoc analysis of the CAVA trial. Thromb Haemost 2020; 120 (08) 1188-1199
• 50 Kim MS, Park HS, Hyun D, Cho SK, Park KB, Do YS. Factors associated with the development of post-thrombotic syndrome in patients with iliofemoral deep venous thrombosis who underwent catheter-directed thrombolysis. Phlebology 2020; 35 (09) 672-678
• 51 Li X, Xie H, Zhang Y, Li H. Individual choice for the aspiration thrombectomy treatment of acute iliofemoral deep venous thrombosis. Ann Vasc Surg 2020; 69: 237-245
• 52 Nakamura H, Anzai H, Kadotani M. Less frequent post-thrombotic syndrome after successful catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Cardiovasc Interv Ther 2021; 36 (02) 237-245
• 53 Tian Y, Huang Z, Luo K, Zhang N, Yuan B. A retrospective comparison of catheter-directed thrombolysis versus pharmacomechanical thrombolysis for treatment of acute lower extremity deep venous thrombosis. Ann Vasc Surg 2021; 74: 306-314
• 54 Zhu J, Ni CF, Dai ZY, Yao LZ, Li WH. A case-controlled study on AngioJet rheolytic thrombectomy and catheter-directed thrombolysis in the treatment of acute lower extremity deep venous thrombosis. Vascular 2020; 28 (02) 177-182
• 55 Li Y, Wang J, He R. et al. Feasibility of anticoagulation using low molecular-weight heparin during catheter-directed thrombolysis for lower extremity deep venous thrombosis. Thromb J 2021; 19 (01) 6
• 56 Abd El-Mabooda EA, Sorourc WA. Acute iliofemoral deep vein thrombosis: does catheter-directed thrombolysis affect outcomes?. Egypt J Surg 2020; 39: 325-337
• 57 Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999; 211 (01) 39-49
• 58 Porter JM, Moneta GL. International Consensus Committee on Chronic Venous Disease. Reporting standards in venous disease: an update. J Vasc Surg 1995; 21 (04) 635-645
• 59 Soosainathan A, Moore HM, Gohel MS, Davies AH. Scoring systems for the post-thrombotic syndrome. J Vasc Surg 2013; 57 (01) 254-261
• 60 Rutherford RB, Padberg Jr FT, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg 2000; 31 (06) 1307-1312
• 61 Vedantham S, Sista AK, Klein SJ. et al; Society of Interventional Radiology and Cardiovascular and Interventional Radiological Society of Europe Standards of Practice Committees. Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 2014; 25 (09) 1317-1325
• 62 Ebben HP, Jongkind V, Wisselink W, Hoksbergen AWJ, Yeung KK. Catheter directed thrombolysis protocols for peripheral arterial occlusions: a systematic review. Eur J Vasc Endovasc Surg 2019; 57 (05) 667-675
• 63 Darwood R, Berridge DC, Kessel DO, Robertson I, Forster R. Surgery versus thrombolysis for initial management of acute limb ischaemia. Cochrane Database Syst Rev 2018; 8 (08) CD002784
• 64 Theodoridis PG, Davos CH, Dodos I. et al. Thrombolysis in acute lower limb ischemia: review of the current literature. Ann Vasc Surg 2018; 52: 255-262
• 65 Jiang J, Tu J, Jia Z. et al. Incidence and outcomes of inferior vena cava filter thrombus during catheter-directed thrombolysis for proximal deep venous thrombosis. Ann Vasc Surg 2017; 38: 305-309
• 66 Kölbel T, Alhadad A, Acosta S, Lindh M, Ivancev K, Gottsäter A. Thrombus embolization into IVC filters during catheter-directed thrombolysis for proximal deep venous thrombosis. J Endovasc Ther 2008; 15 (05) 605-613
• 67 Avgerinos ED, Hager ES, Jeyabalan G, Marone L, Makaroun MS, Chaer RA. Inferior vena cava filter placement during thrombolysis for acute iliofemoral deep venous thrombosis. J Vasc Surg Venous Lymphat Disord 2014; 2 (03) 274-281
• 68 Sharifi M, Bay C, Mehdipour M, Sharifi J, Investigators T. TORPEDO Investigators. Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion (TORPEDO) trial: midterm results. J Endovasc Ther 2012; 19 (02) 273-280
• 69 Vedantham S, Vesely TM, Sicard GA. et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2004; 15 (06) 565-574
• 70 Notten P, Ten Cate-Hoek AJ, Arnoldussen CWKP. et al. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. Lancet Haematol 2020; 7 (01) e40-e49